• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞减灭术联合腹腔内热灌注化疗治疗腹膜表面恶性肿瘤:当前的治疗方法和结果。

Cyto-reductive Surgery combined with Hyperthermic Intra-peritoneal Chemotherapy for Peritoneal Surface Malignancies: current treatment and results.

机构信息

Melanoma and Sarcoma Unit, Veneto Institute of Oncology, National Cancer Institute - IRCCS, Padova, Italy.

出版信息

Cancer Treat Rev. 2012 Jun;38(4):258-68. doi: 10.1016/j.ctrv.2011.07.001. Epub 2011 Jul 31.

DOI:10.1016/j.ctrv.2011.07.001
PMID:21807464
Abstract

Cyto-reductive Surgery (CS) combined with Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) as loco-regional treatment of Peritoneal Surface Malignancies (PSM) has increasingly gained acceptance in clinical practice. This review summarizes the more relevant studies on this topic. Indications, pre-operative work-up, technical aspects, outcome and future directions of this combined approach in the treatment of Peritoneal Surface Malignancies are discussed here and proposed in an informative and didactic manner.

摘要

细胞减灭手术(CS)联合腹腔内热灌注化疗(HIPEC)作为腹膜表面恶性肿瘤(PSM)的局部区域治疗方法,在临床实践中越来越被接受。本文综述了这一专题的相关研究。本文讨论了该联合治疗方法在腹膜表面恶性肿瘤治疗中的适应证、术前准备、技术方面、结果和未来方向,并以信息性和教学性的方式提出建议。

相似文献

1
Cyto-reductive Surgery combined with Hyperthermic Intra-peritoneal Chemotherapy for Peritoneal Surface Malignancies: current treatment and results.细胞减灭术联合腹腔内热灌注化疗治疗腹膜表面恶性肿瘤:当前的治疗方法和结果。
Cancer Treat Rev. 2012 Jun;38(4):258-68. doi: 10.1016/j.ctrv.2011.07.001. Epub 2011 Jul 31.
2
[Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].[细胞减灭术联合腹腔热灌注化疗(IHPC)治疗腹膜癌病:术后发病率、死亡率及短期随访]
Ann Ital Chir. 2008 Jul-Aug;79(4):231-9.
3
[Treatment of peritoneal carcinomatosis with surgery and hyperthermic peroperative intraperitoneal chemotherapy (HIPEC): new aspects and validated indications].[手术联合术中腹腔热灌注化疗(HIPEC)治疗腹膜癌:新进展与有效适应证]
Bull Cancer. 2008 Jan;95(1):141-5. doi: 10.1684/bdc.2008.0553.
4
Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for peritoneal carcinomatosis in an experimental model.腹腔热灌注化疗在细胞减灭术后腹膜转移瘤实验模型中的应用。
Br J Surg. 2010 Dec;97(12):1874-80. doi: 10.1002/bjs.7249. Epub 2010 Aug 30.
5
Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy.热灌注腹腔化疗中的药物、载体溶液及温度
J Surg Oncol. 2008 Sep 15;98(4):247-52. doi: 10.1002/jso.21051.
6
[Peritoneal carcinomatosis of colorectal cancer: cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].[结直肠癌腹膜癌转移:细胞减灭术与腹腔热灌注化疗]
Dtsch Med Wochenschr. 2011 Sep;136(36):1811-4. doi: 10.1055/s-0031-1286108. Epub 2011 Aug 31.
7
[Updated treatment of peritoneal carcinomas: a review].[腹膜癌的最新治疗:综述]
Minerva Chir. 2007 Dec;62(6):459-76.
8
Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).经手术细胞减灭术和腹腔内热灌注化疗(HIPEC)治疗的多囊性及高分化乳头状腹膜间皮瘤。
Ann Surg Oncol. 2007 Oct;14(10):2790-7. doi: 10.1245/s10434-007-9475-8. Epub 2007 Jul 28.
9
Anesthetic management in patients undergoing hyperthermic chemotherapy.行高温化疗患者的麻醉管理。
Curr Opin Anaesthesiol. 2012 Jun;25(3):348-55. doi: 10.1097/ACO.0b013e32835347b2.
10
Long-term results of cytoreduction and HIPEC followed by systemic chemotherapy.细胞减灭术及腹腔热灌注化疗联合全身化疗的长期疗效
Cancer J. 2009 May-Jun;15(3):212-5. doi: 10.1097/PPO.0b013e3181a58d7c.

引用本文的文献

1
HIPEC as a risk factor for postoperative coagulopathy after cytoreductive surgery for peritoneal metastases.腹腔热灌注化疗(HIPEC)作为细胞减灭术治疗腹膜转移术后凝血功能障碍的一个危险因素。
Updates Surg. 2022 Oct;74(5):1715-1723. doi: 10.1007/s13304-022-01340-3. Epub 2022 Aug 6.
2
The role of chemotherapy in the treatment of advanced appendiceal cancers: summary of the literature and future directions.化疗在晚期阑尾癌治疗中的作用:文献综述与未来方向
Ther Adv Med Oncol. 2022 Jul 23;14:17588359221112478. doi: 10.1177/17588359221112478. eCollection 2022.
3
Role of Epithelial-Mesenchymal Plasticity in Pseudomyxoma Peritonei: Implications for Locoregional Treatments.
上皮-间质可塑性在腹膜假黏液瘤中的作用:对局部治疗的启示
Int J Mol Sci. 2020 Nov 30;21(23):9120. doi: 10.3390/ijms21239120.
4
Clinical and predictive value of blood lactate levels during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): a comparative analysis.在细胞减灭术和腹腔热灌注化疗(HIPEC)期间血液乳酸水平的临床和预测价值:比较分析。
Updates Surg. 2021 Feb;73(1):313-319. doi: 10.1007/s13304-020-00908-1. Epub 2020 Nov 4.
5
Activity ex vivo of cytotoxic drugs in patient samples of peritoneal carcinomatosis with special focus on colorectal cancer.细胞毒性药物在腹膜癌病患者样本中的体外活性,特别关注结直肠癌
BMC Cancer. 2013 Sep 24;13:435. doi: 10.1186/1471-2407-13-435.
6
Peritoneal carcinomatosis of colorectal origin: Incidence, prognosis and treatment options.结直肠来源的腹膜癌病:发生率、预后和治疗选择。
World J Gastroenterol. 2012 Oct 21;18(39):5489-94. doi: 10.3748/wjg.v18.i39.5489.